Men and women develop heart valve disease in distinctly different ways, and research suggests gut bacteria may explain why. According to Gram Research analysis, women typically develop scarred, stiff valves later in life with less calcification, while men more often develop heavily calcified valves earlier—differences potentially driven by their different gut bacteria composition and the metabolites those bacteria produce, influenced by sex hormones like estrogen and testosterone.
A new review reveals that men and women develop heart valve problems in distinctly different ways, and gut bacteria may play a surprising role. Women typically develop a stiffer, more scarred valve disease later in life, while men more often experience calcified (hardened) valves earlier. According to Gram Research analysis, the bacteria living in our intestines produce different substances in men versus women—influenced by hormones and diet—that may explain why their heart valve disease looks so different. This discovery could eventually lead to personalized treatments based on sex and microbiome health.
Key Statistics
A 2026 narrative review in Biology of Sex Differences found that women with aortic stenosis typically present at older ages with more pronounced symptoms and fibrotic valve changes, while men show predominance of calcific disease with more extensive aortic valve calcification.
Research reviewed in the 2026 Biology of Sex Differences analysis indicates that men tend to have higher levels of TMAO and indoxyl sulfate—bacterial metabolites linked to inflammation—driven by a Firmicutes-enriched microbiota, while women generally exhibit more diverse and cardioprotective microbiota profiles shaped by estrogen.
According to the 2026 review, women’s more diverse gut microbiota, influenced by estrogen and dietary habits, may explain their lower levels of pro-calcific metabolites and fibrotic rather than calcified valve phenotype in aortic stenosis.
The Quick Take
- What they studied: How and why men and women develop heart valve disease differently, and whether gut bacteria might explain these differences
- Who participated: This was a review article that analyzed existing research rather than conducting a new study with participants
- Key finding: Women tend to develop fibrotic (scarred) valve disease with less calcification, while men develop heavily calcified valves—differences that may be linked to their different gut bacteria and hormone levels
- What it means for you: In the future, doctors might be able to predict and treat heart valve disease differently for men and women based on their gut health, though more research is needed before this becomes standard practice
The Research Details
This is a narrative review, which means researchers read and summarized existing scientific studies rather than conducting their own experiment. The authors examined published research on how aortic stenosis (a narrowing of the heart valve) affects men and women differently, and they looked at studies about gut bacteria and heart health. They then connected these pieces of information to propose a new theory: that the differences in gut bacteria between men and women might explain why their heart valve disease develops differently.
The researchers focused on three main areas: how the disease presents differently in men versus women, the biological pathways involved, and the role of gut microbiota. They paid special attention to specific bacterial metabolites (substances produced by bacteria) called TMAO and indoxyl sulfate, which previous research has linked to heart problems.
A narrative review is valuable because it synthesizes existing knowledge and proposes new connections that haven’t been tested yet. This type of research helps scientists and doctors understand what we know, identify gaps in our knowledge, and suggest directions for future studies. In this case, the review connects three important areas—sex differences, heart disease, and gut health—that haven’t been thoroughly examined together before.
As a narrative review, this article presents a hypothesis rather than definitive proof. The strength of the conclusions depends on the quality of the studies it reviewed. The authors acknowledge they’re proposing a framework for future research, not proving cause-and-effect. Readers should understand this is an expert’s informed perspective on existing research, not a final answer. More direct studies testing these connections in real patients are needed.
What the Results Show
The review identifies clear patterns in how men and women experience aortic stenosis. Women typically develop the disease later in life (at older ages), experience more severe symptoms despite less blood flow through the valve, and show more fibrotic (scarred, stiff) changes in their valve tissue. Their heart muscle tends to thicken in a concentric pattern (thickening inward). Men, by contrast, develop the disease with more extensive calcification (hardening from mineral deposits), show eccentric heart remodeling (thickening in a different pattern), and tend to have more inflammatory changes.
The review proposes that gut bacteria composition differs between men and women in ways that could explain these patterns. Women generally have more diverse gut bacteria and higher levels of protective bacterial species, influenced by estrogen levels and dietary choices. This diverse microbiota may produce lower levels of harmful metabolites. Men tend to have gut bacteria dominated by Firmicutes (a type of bacteria), which produce higher levels of TMAO and indoxyl sulfate—substances linked to inflammation and calcification.
These bacterial metabolites appear to influence the molecular pathways that determine whether a valve becomes calcified or fibrotic. The review suggests that the same gut bacteria differences that affect overall cardiovascular health may specifically influence how the aortic valve changes in men versus women.
The review also highlights that estrogen and testosterone (sex hormones) directly influence both gut bacteria composition and the inflammatory responses in heart valve tissue. Women’s higher estrogen levels may promote beneficial bacteria and reduce calcification-promoting pathways. The review notes that dietary factors—which differ between men and women on average—also shape the microbiota and its metabolite production. Additionally, the authors suggest that frailty in older women with aortic stenosis may be partly related to microbiota-driven inflammation, opening new avenues for intervention.
Previous research has documented that men and women experience aortic stenosis differently, but most explanations focused on anatomical differences (valve size, heart structure) and hemodynamic factors (blood flow patterns). This review is among the first to systematically propose that gut microbiota and its metabolites may be a significant contributor to these sex-specific differences. The connection between TMAO, indoxyl sulfate, and cardiovascular disease is well-established in recent research, but applying this specifically to sex differences in aortic stenosis represents a novel synthesis of existing knowledge.
As a narrative review, this article presents a hypothesis rather than proven facts. The authors acknowledge that direct evidence linking microbiota differences to sex-specific aortic stenosis patterns is still limited. Most studies cited were conducted in general cardiovascular disease populations, not specifically in aortic stenosis patients. The review cannot establish cause-and-effect relationships—it can only suggest plausible connections. Additionally, human microbiota research is complex and individual variation is high, so the patterns described may not apply equally to all men and women. Clinical trials specifically testing microbiota-targeted interventions in aortic stenosis patients are needed to validate these hypotheses.
The Bottom Line
Current evidence does not yet support specific microbiota-targeted treatments for aortic stenosis based on sex. However, general heart-healthy practices that support beneficial gut bacteria—such as eating fiber-rich foods, maintaining a Mediterranean-style diet, regular physical activity, and avoiding unnecessary antibiotics—remain sound advice. These practices are supported by strong evidence for overall cardiovascular health. Patients with aortic stenosis should continue following their cardiologist’s recommendations for monitoring and treatment. (Confidence level: Moderate for general microbiota-supporting practices; Low for sex-specific microbiota interventions in aortic stenosis specifically)
This research is most relevant to cardiologists and researchers studying aortic stenosis, as it suggests new directions for investigation. Women and men with aortic stenosis or at risk for it may find this information interesting as it explains why their disease may look different from the opposite sex. Healthcare providers may eventually use this framework to develop personalized prevention and treatment strategies. People without heart disease should not assume they need microbiota interventions based on this review alone.
This research is still in the hypothesis stage. It will likely take 5-10 years of additional research before microbiota-based interventions could be tested in clinical trials for aortic stenosis. If such interventions prove effective, it could take another 5+ years before they become standard medical practice. In the near term, the practical benefit is understanding why your sex influences how aortic stenosis develops, which may help with early detection and symptom management.
Frequently Asked Questions
Why do men and women get different types of heart valve disease?
Sex hormones like estrogen and testosterone influence both gut bacteria composition and inflammation in heart valve tissue. Men’s gut bacteria tend to produce more calcification-promoting substances, while women’s more diverse microbiota may protect against calcification, leading to different disease patterns.
Can changing my gut bacteria help prevent aortic stenosis?
While direct evidence in aortic stenosis patients is limited, eating fiber-rich foods and maintaining a healthy diet that supports beneficial bacteria is linked to better cardiovascular health overall. Talk to your cardiologist about whether microbiota-focused dietary changes are appropriate for your situation.
What are TMAO and indoxyl sulfate and why do they matter?
These are substances produced by gut bacteria that research links to inflammation and calcification in blood vessels and heart valves. Men tend to have higher levels of these metabolites, which may contribute to their more calcified valve disease compared to women.
Is this research ready to change how doctors treat aortic stenosis?
Not yet. This review proposes a hypothesis based on existing research but doesn’t provide definitive proof. Clinical trials testing microbiota-targeted treatments specifically in aortic stenosis patients are needed before this becomes standard medical practice.
What can I do now based on this research if I have aortic stenosis?
Continue following your cardiologist’s treatment plan. Additionally, support your gut health through a fiber-rich diet, fermented foods, regular exercise, and avoiding unnecessary antibiotics—practices that benefit overall cardiovascular health while researchers continue investigating microbiota’s specific role.
Want to Apply This Research?
- Track dietary fiber intake (target: 25-30g daily) and note any gastrointestinal symptoms or changes. Users can log meals and the app can calculate fiber content, helping identify whether diet changes correlate with symptom patterns in aortic stenosis.
- Increase consumption of fiber-rich foods (vegetables, whole grains, legumes) and fermented foods (yogurt, kefir, sauerkraut) that support beneficial gut bacteria. The app could provide meal suggestions and track adherence to a microbiota-friendly diet pattern.
- Over 8-12 weeks, monitor how dietary changes correlate with energy levels, symptom severity, and overall well-being. Users can rate daily symptoms and energy on a simple scale while the app tracks dietary patterns, helping identify personal connections between gut health practices and heart-related symptoms.
This article summarizes a narrative review article and presents a hypothesis about potential connections between gut microbiota and sex-specific differences in aortic stenosis. It is not medical advice. The findings described are based on existing research synthesis, not new clinical evidence. If you have aortic stenosis or symptoms of heart valve disease, consult your cardiologist for diagnosis and treatment recommendations. Do not make changes to your diet, supplements, or medications based on this article without discussing them with your healthcare provider first. Microbiota-targeted interventions for aortic stenosis are not yet standard medical practice and require further research.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.